FDA
label_change
· 2009-04-23
FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) submitted by Novartis Pharmaceuticals Corporation. The decision involves labeling updates …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRILEPTAL (OXCARBAZEPINE)